Andrea Pellagatti

Clinical and biological implications of driver mutations in myelodysplastic syndromes

Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati et al. · Blood · 2013 · 1.8K citations

Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts

Elli Papaemmanuil, Mario Cazzola, Jacqueline Boultwood et al. · New England Journal of Medicine · 2011 · 1.2K citations · Full text

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Elsa Bernard, Heinz Tuechler, Peter L. Greenberg et al. · NEJM Evidence · 2022 · 746 citations · Full text

Mixed-phenotype Acute Leukemia, Prognosis, Genetic Epidemiology +20

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian et al. · Nature Medicine · 2020 · 606 citations · Full text

Hematological Malignancy, Chromatin, Genome Stability +11

Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

Petter Woll, Una Kjällquist, Onima Chowdhury et al. · Cancer Cell · 2014 · 318 citations · Full text

Hematological Malignancy, Bone Marrow Failure, Myelodysplastic Syndromes +9